Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Gonzalez-Ortiz

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2024
Analytical and clinical validation of Alzheimer's disease blood biomarkers with a focus on plasma p-tau217Fernando Gonzalez-Ortiz, Thomas K Karikari, Kaj Blennow
Neurology|March 28, 2024
Association of Plasma Brain-Derived Tau With Functional Outcome After Ischemic StrokeTara M Stanne, Fernando Gonzalez-Ortiz, Cecilia Brännmark, et al.
Molecular Neurodegeneration|March 17, 2023
Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applicationsFernando Gonzalez-Ortiz, Przemysław R Kac, Wagner S Brum, et al.
Clinical Chemistry and Laboratory Medicine|November 7, 2025
Comparative analysis of plasma p-tau217 immunoassays: challenges for standardization and harmonizationBurak Arslan, Johan Gobom, Ulf Andreasson, et al.
Journal of Neurosurgery|April 18, 2025
Blood biomarkers for brain injury in chronic subdural hematomas: postoperative dynamics and relation to long-term outcomeTeodor Svedung Wettervik, Caroline Lindblad, Felix Axelsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersDaniel C Bowie, Yara Yakoub, Valentin Ourry, et al.
Brain Communications|November 6, 2024
Plasma phosphorylated-tau217 is increased in Niemann-Pick disease type CFernando Gonzalez-Ortiz, Thomas K Karikari, Danielle Taylor-Te Vruchte, et al.
Alzheimer'S Research & Therapy|May 11, 2022
Diagnostic value of serum versus plasma phospho-tau for Alzheimer's diseasePrzemysław R Kac, Fernando Gonzalez-Ortiz, Joel Simrén, et al.
Journal of Internal Medicine|December 6, 2024
Plasma brain-derived tau correlates with cerebral infarct volumeFernando Gonzalez-Ortiz, Lukas Holmegaard, Björn Andersson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 9, 2025
Brain-derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementiaCassandra Marotta, Fernando Gonzalez-Ortiz, Michael Turton, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2024
Analytical and clinical validation of Alzheimer's disease blood biomarkers with a focus on plasma p-tau217Fernando Gonzalez-Ortiz, Thomas K Karikari, Kaj Blennow
Neurology|March 28, 2024
Association of Plasma Brain-Derived Tau With Functional Outcome After Ischemic StrokeTara M Stanne, Fernando Gonzalez-Ortiz, Cecilia Brännmark, et al.
Molecular Neurodegeneration|March 17, 2023
Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applicationsFernando Gonzalez-Ortiz, Przemysław R Kac, Wagner S Brum, et al.
Clinical Chemistry and Laboratory Medicine|November 7, 2025
Comparative analysis of plasma p-tau217 immunoassays: challenges for standardization and harmonizationBurak Arslan, Johan Gobom, Ulf Andreasson, et al.
Journal of Neurosurgery|April 18, 2025
Blood biomarkers for brain injury in chronic subdural hematomas: postoperative dynamics and relation to long-term outcomeTeodor Svedung Wettervik, Caroline Lindblad, Felix Axelsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersDaniel C Bowie, Yara Yakoub, Valentin Ourry, et al.
Brain Communications|November 6, 2024
Plasma phosphorylated-tau217 is increased in Niemann-Pick disease type CFernando Gonzalez-Ortiz, Thomas K Karikari, Danielle Taylor-Te Vruchte, et al.
Alzheimer'S Research & Therapy|May 11, 2022
Diagnostic value of serum versus plasma phospho-tau for Alzheimer's diseasePrzemysław R Kac, Fernando Gonzalez-Ortiz, Joel Simrén, et al.
Journal of Internal Medicine|December 6, 2024
Plasma brain-derived tau correlates with cerebral infarct volumeFernando Gonzalez-Ortiz, Lukas Holmegaard, Björn Andersson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 9, 2025
Brain-derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementiaCassandra Marotta, Fernando Gonzalez-Ortiz, Michael Turton, et al.
Pageof 8